SciELO - Scientific Electronic Library Online

 
vol.29 número2El discurso de la religión en la jurisprudencia constitucional colombiana: ¿una narrativa de transformación?El solve et repete en el ambiente tributario. Apuntes críticos en torno a las tesis que justifican su exigencia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Díkaion

versión impresa ISSN 0120-8942versión On-line ISSN 2027-5366

Resumen

DUQUE GIRALDO, Mateo. Proposals for the Adequate Incorporation of the Right to Try: The United States-Colombia Case. Díkaion [online]. 2020, vol.29, n.2, pp.411-440.  Epub 12-Abr-2021. ISSN 0120-8942.  https://doi.org/10.5294/dika.2020.29.2.4.

This research paper puts forward a set of academic proposals for the Colombian health care system’s adequate incorporation of the right to try experimental treatments conceived in the United States. It explains the differences between the Colombian and the American health models regarding access to non-conventional drugs. A comparative qualitative method is used, which, by contrasting, would provide solutions to incorporate the right appropriately into the national health model. The research concludes that, for the right to be adequately adopted, it is crucial to take out voluntary policies that ensure experimental treatments, introduce presumption of fact on patients’ economic capacity to avoid shifting the burden of proof, eliminate medical committees for the approval of these drugs-notwithstanding the fact that physicians may consult their risks and benefits with other medical bodies-, and incentivize credits and tax exemptions for insurers and manufacturers.

Palabras clave : Incorporating the right to try; differences between Colombia and the United States; role of patients, manufacturers, and insurers; research drugs and procedures.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )